Welcome to the Clinical Criteria Page
This page provides the clinical criteria documents for all injectable, infused, or implanted prescription drugs and therapies covered under the medical benefit. The effective dates for using these documents for clinical reviews are communicated through the Provider notification process.
To determine if a code requires authorization, use the
NY Prior Authorization lookup tool
or
WNY Precertification lookup tool
The New York Medicaid state-specific clinical criteria information is alphabetized below. Not all drugs requiring authorization have New York Medicaid State specific criteria. If a code requires authorization and the clinical criteria document is not found in the list below, please utilize the following link for additional criteria.Clinical Criteria
New York Specific Policies
Clinical Criteria | Associated Medications (as applicable) | Document Number | Coding |
---|---|---|---|
Gonadotropin Releasing Hormone Analogs for the Treatment of Non-Oncologic Indications | Fensolvi, Lupron Depot, Lupron Depot-Ped, Lupaneta Pack, Supprelin LA 12 month implant, Synarel Nasal Spray, Triptodur, Vantas, Zoladex | CC-0061 - NY | J1675, J1950, J1951, J3315, J3316, J9202, J9217 J9225, J9226, S9560 |
Hyaluronan Injections | Durolane, GenVisc 850, Hyalgan, Supartz, Hymovis, Euflexxa, Orthovisc, Synvisc, Synvisc-One, Gel-One, Monovisc, Gel-Syn, trivisc, synojoynt, Triluron, Visco-3 | CC-0006 - NY | J7318, J7320, J7321, J7322, J7323, J7324, J7325, J7326, J7327, J7328, J7329, J7331, J7332, J7333 |
Amondys | CC-0189 - NY | J1426 | |
Exondys | CC-0044 - NY | J1428 | |
Viltepso | CC-0172 - NY | J1427 | |
Vyondys | CC-0152 - NY | J1429 | |
Gonadotropin Releasing Hormone Analogs for the Treatment of Oncologic Indications | Lupron Depot 3.75, Zoladex, Lupron, leuprolide, goserelin | CC-0102 - NY | J1950, J9202, J9218, S9560 |
Gonadotropin Releasing Hormone Analogs for the Treatment of Oncologic Indications | Lupron Depot 3.75, Lupron Depot 3-month 11.25, Lupron. leuprolide, goserelin | CC-0102 - NY | J1950, J9218, S9560 |
Gonadotropin Releasing Hormone Analogs for the Treatment of Oncologic Indications | Trelstar, Trelstar LA, Firmagon, Zoladex, Eligard, Lupron Depot 7.5, Lupron Depot 22.5 mg (3-month), Lupron Depot 30 mg (4-month), Lupron Depot 45 mg (6-month), Lupron, Vantas, Camcevi, leuprolide, goserelin | CC-0102 - NY | J3315, J9155, J9202, J9217, J9218, J9225, J1952, S9560 |
Gonadotropin Releasing Hormone Analogs for the Treatment of Oncologic Indications | histrelin acetate, Lupron Depot 3.75, Trelstar, Trelstar LA, Firmagon, Zoladex, Eligard, Lupron Depot, Lupron | CC-0102 - NY | J1675, J1950, J3315, J9155, J9202, J9217, J9218 |
Gonadotropin Releasing Hormone Analogs for the Treatment of Oncologic Indications | Eligard 7.5 mg (1 Month), Eligard 22.5 mg (3 Month), Lupron Depot 7.5 mg (1 Month), Lupron Depot 22.5 mg (3 Month), leuprolide, goserelin | CC-0102 - NY | J9217, S9560 |
(Note: in the case of a clinical criteria document being listed on both sites, please utilize those listed directly above.)
If you have questions or feedback, please contact druglist@carelon.com.